Volume 20 Number 7

This issue of EuroIntervention includes a debate on the use of cangrelor as described in the current guidelines and whether it should be employed – or not – in P2Y12 receptor inhibitor-naïve patients undergoing percutaneous coronary intervention. There is a state-of-the-art review on the percutaneous treatment of pulmonary embolism; original research on the efficacy of antithrombotic monotherapy according to revascularisation; a comparison of carotid artery stenting- and carotid endarterectomy-related outcomes; the possible rapid onset effects of a crushed prasugrel loading dose on STEMI patients suffering from a large MI; a research correspondence on the long-term data of Fantom BRS; and more...